$46.83 -0.61 (-1.29%)
11/27/2009 1:02 PM

Varian Medical Systems, Inc. (VAR)

CAPS Rating: 5 out of 5

The Company designs, manufactures, sells and services advanced equipment and software products for treating cancer with radiation.

Results 1 - 20 of 65 1 2 3 4 Next »

Recs

0
Member Avatar Tasm01 (43.17) Submitted: 10/16/2009 5:17:25 PM : Outperform Start Price: $41.30 VAR Score: +12.93

Technical indicators bullish

Recs

0
Member Avatar 59special (< 20) Submitted: 10/10/2009 11:28:06 AM : Outperform Start Price: $40.18 VAR Score: +14.87

2/122 in Health Care Equipment -(69.8@B/A)

Recs

0
Member Avatar yooperking (91.45) Submitted: 8/24/2009 3:06:15 PM : Outperform Start Price: $40.63 VAR Score: +8.00

Louis Basenese (Oxford Club) says, "If you don't jump at the opportunity to buy shares at these levels, you might never get another chance."

Recs

0
Member Avatar jemsa (83.96) Submitted: 8/20/2009 2:28:27 PM : Outperform Start Price: $37.89 VAR Score: +14.30

caps 5, stockscouter10

Recs

1
Member Avatar SuperCharge (98.60) Submitted: 7/25/2009 5:05:09 PM : Outperform Start Price: $36.11 VAR Score: +16.72

Consistent and solid performer with a bit of moat & room to grow. Among the more appealing stocks in my newest stock screener. Not that I expect it to because there's other factors involved, but forward valuation (14.2 P/E) on the past 5 yrs. Avg. P/E (27+) would put this stock at about $66. $50 is certainly reasonable in the not too distant future.

Here's the criteria that brought up Varian.

(Market Capitalization (mil $) > 150)
and (PEG Ratio <= .65)
and (Cash / Total Assets % >= 10)
and ((Cash - Long Term Debt) / Market Cap % >= -1)
and (Free Cash Flow / Market Cap % >= 0.73)
and (Return on Equity % - Trailing 12 Months >= 25)
and (Return on Equity % - Year 1 >= 13)
and (Return on Equity % - Year 2 >= 13)
and (Free Cash Flow ($ mil) - Trailing 12 Months >= 0)
and (Free Cash Flow ($ mil) - Year 1 >= 0)
and (Free Cash Flow ($ mil) - Year 2 >= 0)

Recs

0
Member Avatar Thleter (97.22) Submitted: 7/16/2009 1:28:29 PM : Outperform Start Price: $33.18 VAR Score: +23.82

Just found this one recently while checking some of the top performer picks (ten mile) and really liked what I saw - even added to my real portfolio.

Recs

0
Member Avatar holopoj (57.30) Submitted: 7/16/2009 11:13:31 AM : Outperform Start Price: $33.28 VAR Score: +22.63

Solid fundamentals. Business will pick up again after the recession

Recs

0
Member Avatar Thlete (36.10) Submitted: 7/14/2009 9:29:21 AM : Outperform Start Price: $32.56 VAR Score: +21.55

This one caught my eye as I checked out tenmiles recent picks. I like what I'm finding while researching this company and I don't have any picks in the medical sector, so this seems like a good fit.

Recs

2
Member Avatar imup (35.22) Submitted: 6/23/2009 11:22:37 PM : Outperform Start Price: $36.26 VAR Score: +11.17

I've been a Radiation Therapist for 14 years... Varian makes the best linear accelerator out there. This company started in my home town of San Carlos, CA. They are now in Palo Alto. They make an excellent product and their service is excellent. They are always cutting edge with new technology... always innovative and finding ways to spare more normal tissue which is the goal in irradicating tumors. I would buy below $36.

Recs

0
Member Avatar pp12000 (42.24) Submitted: 6/22/2009 1:49:13 AM : Outperform Start Price: $36.95 VAR Score: +5.92

obama, earnings, sales, PE

Recs

0
Member Avatar jbs4radio (< 20) Submitted: 6/16/2009 2:42:32 AM : Outperform Start Price: $36.11 VAR Score: +10.93

PEG = 0.7

Recs

0
Member Avatar SimonSaysSell (35.41) Submitted: 6/10/2009 11:14:53 AM : Outperform Start Price: $36.90 VAR Score: +9.37

Bandwagoning here.

Recs

1
Member Avatar mrindependent (98.84) Submitted: 6/7/2009 12:04:46 AM : Outperform Start Price: $36.26 VAR Score: +11.17

Shadowing Ten Miles. My independent research revealed that the company's revenues have held steady through this downturn, which is no small trick. I read their annual letter an learned that besides being the number one player in cancer devices (i.e.- radiation/x-ray/oncology) they are also a rapidly growing player in the x-ray security inspection business. They have products that allow inspectors to use x-ray inspection on ship cargos. Personally, I believe that cancer treatments are going to stay front and center for growth in the medical arena. Recent progress is inspiring. The company appears safe from Obama because: (1) as a device maker, it is already subject to competition from international manufacturers (2) Obama should like the fact that the company's products allow elimination of paper x-ray prints - everything is digital and (3) the fact that the company has so many interlocking patents makes it difficult for people to product cheap knock offs. Although the company sells fo 4X book value, this is cheap compared to the company's historic multiples and compared to my estimate of its intrinsic value. I expect to hold this company until it doubles in value. Then I will see if I want to ride it for a triple.

Recs

0
Member Avatar rranly (59.71) Submitted: 6/4/2009 8:05:17 PM : Outperform Start Price: $36.84 VAR Score: +11.21

solid

Recs

0
Member Avatar snapper99man (76.42) Submitted: 6/2/2009 5:52:56 PM : Outperform Start Price: $38.11 VAR Score: +5.15

Tenmiles

Recs

0
Member Avatar BustaCAPS (69.64) Submitted: 5/29/2009 4:21:20 PM : Outperform Start Price: $37.07 VAR Score: +8.13

tenmile play

Recs

0
Member Avatar firetiger77 (28.04) Submitted: 5/29/2009 11:50:55 AM : Outperform Start Price: $35.45 VAR Score: +10.33

high CAPS rating + tenmiles idea; PE a little high, but this is good for growth

Recs

3
Member Avatar tenmiles (99.99) Submitted: 5/28/2009 9:41:52 AM : Outperform Start Price: $35.80 VAR Score: +8.39

I agree with Morgan 628 and other long Fools on this one. Another medical growth story trading like a value stock. Strong position in the oncology market; consistent EPS growth over the last decade; little debt with mid-teen forward p/e about half of ROE. Good stock to sock away for a few years in the mid-30's - could even catch a takeover bid, but absent that will still likely outperform the broad markets fairly handily from this level for those with 3-5 year time horizon.

Recs

0
Member Avatar bclan13 (99.44) Submitted: 4/29/2009 1:42:03 AM : Outperform Start Price: $35.18 VAR Score: +5.13

I think this company has positioned itself at the top of the information food chain in oncology - a uniquely strategic position bound to provide considerable shareholder return if the vision remains there.

Recs

0
Member Avatar minimidgy (97.85) Submitted: 4/10/2009 1:46:49 AM : Outperform Start Price: $33.21 VAR Score: +10.63

Takeover target, heavy options activity.

Results 1 - 20 of 65 1 2 3 4 Next »

Featured Broker Partners